Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (2E)-Hexenoic Acid SCHEMBL28617152 | 1.00 | HCAR2 (0.67) | HCAR2MAPTALDH1A1TTRDPP4 | |
| Ethyl Fumarate SCHEMBL27194590 | 0.94 | HCAR2 (0.77) | HCAR2MAPTALDH1A1TTRDPP4 | |
| SCHEMBL755909 | 0.94 | MAPT (0.66) | HCAR2MAPTALDH1A1TTRDPP4 | |
| SCHEMBL29430520 | 0.94 | MAPT (0.66) | HCAR2MAPTALDH1A1TTRDPP4 | |
| SCHEMBL265418 | 0.94 | MAPT (0.66) | HCAR2MAPTALDH1A1TTRDPP4 | |
| Ethylene SCHEMBL27926804 | 0.90 | MAPT (0.61) | HCAR2MAPTALDH1A1TTRDPP4 | |
| SCHEMBL6322239 | 0.89 | MAPT (0.66) | HCAR2MAPTALDH1A1TTRDPP4 | |
| Trimethylammonium SCHEMBL27821912 | 0.88 | MAPT (0.59) | HCAR2MAPTALDH1A1TTRDPP4 | |
| SCHEMBL4582673 | 0.86 | MAPT (0.68) | HCAR2MAPTALDH1A1ATMCYP3A4 | |
| SCHEMBL4936379 | 0.86 | MAPT (0.73) | HCAR2MAPTALDH1A1TTRDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240058293-A1 | Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto | UNIV EMORY (US) | 2024-02-22 | — | — | US | claimed |
| US-11826336-B2 | Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto | EMORY UNIVERSITY (US) | 2023-11-28 | — | — | US | claimed |
| CN-116492339-A | Composition, application thereof and pharmaceutical preparation | 深圳君圣泰生物技术有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-111295203-B | Methods and compositions for treating inflammatory bowel disease | 深圳君圣泰生物技术有限公司 | 2022-09-06 | — | — | CN | claimed |
| US-20220142962-A1 | METHODS OF TREATING HYPERCHOLESTEROLEMIA | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2022-05-12 | — | — | US | claimed |
| US-11207286-B2 | Self-emulsifying composition of w3 fatty acid | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2021-12-28 | — | — | US | claimed |
| US-20210283090-A1 | Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto | UNIV EMORY (US) | 2021-09-16 | — | — | US | claimed |
| US-11026913-B2 | Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto | EMORY UNIVERSITY (US) | 2021-06-08 | — | — | US | claimed |
| US-11007173-B2 | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2021-05-18 | — | — | US | claimed |
| US-10888537-B2 | Pharmaceutical compositions comprising omega-3 fatty acids | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2021-01-12 | — | — | US | claimed |
| US-20130324607-A1 | METHODS OF TREATING HYPERCHOLESTEROLEMIA | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2013-12-05 | — | — | US | claimed |
| EP-2433630-A1 | SELF-EMULSIFYING COMPOSITION OF 3 FATTY ACID | Mochida Pharmaceutical Co., Ltd. (JP) | 2012-03-28 | — | — | EP | claimed |
| US-20120065264-A1 | SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2012-03-15 | — | — | US | claimed |
| US-20100273878-A1 | PREVENTIVE OR THERAPEUTIC DRUG FOR ALZHEIMER-TYPE DEMENTIA | HASHIZUME KIYOSHI | 2010-10-28 | — | — | US | claimed |
| US-20090286879-A1 | Preventive or Therapeutic Drug for Alzheimer-Type Dementia | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2009-11-19 | — | — | US | claimed |
| US-20090209644-A1 | LIPOTOXICITY RELIEVING AGENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2009-08-20 | — | — | US | claimed |
| US-20080200707-A1 | Lipotoxicity Relieving Agent | MOCHIDA-PHARMACEUTICALS PHARMACEUTICAL CO., LTD. (JP) | 2008-08-21 | — | — | US | claimed |
| EP-1955698-A1 | PREVENTIVE/THERAPEUTIC AGENT FOR ALZHEIMER'S DEMENTIA | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2008-08-13 | — | — | EP | claimed |
| EP-1834639-A1 | REMEDIAL AGENT FOR FAT TOXICITY | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2007-09-19 | — | — | EP | claimed |
| US-5120556-A | Adding defatted corn germ | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1992-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10888537-B2 | Pharmaceutical compositions comprising omega-3 fatty acids | ELOVL3, ELOVL6, ELOVL5 | HCAR2 344/4885MAPT 3257/4885ALDH1A1 2432/4885 |
| US-11007173-B2 | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same | HMGCR, ELOVL3, SCD | HCAR2 90/4885MAPT 3104/4885ALDH1A1 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.